General Information of Drug (ID: DMXB7V8)

Drug Name
Naxitamab
Indication
Disease Entry ICD 11 Status REF
Neuroblastoma 2D11.2 Approved [1]
Osteosarcoma 2B51 Phase 2 [2]
Affected Organisms
Humans
ATC Code
L01FX21: Naxitamab
L01FX: Other monoclonal antibodies and antibody drug conjugates
L01F: MONOCLONAL ANTIBODIES AND ANTIBODY DRUG CONJUGATES
L01: ANTINEOPLASTIC AGENTS
L: ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS
Cross-matching ID
UNII
9K8GNJ2874
DrugBank ID
DB15965
TTD ID
D0HI5D
Repurposed Drugs (RPD) Click to Jump to the Detailed RPD Information of This Drug

References

1 Drugs@FDA. U.S. Food and Drug Administration. U.S. Department of Health Human Services. 2020
2 Clinical pipeline report, company report or official report of the Pharmaceutical Research and Manufacturers of America (PhRMA)